Life Science Innovation – Trends in Single Cell Analysis #9

Life Science Innovation – Trends in Single Cell Analysis #9

Wann

17. Juli 2024    
16:00 - 18:00

Anmeldung

Anmeldung geschlossen

Wo

Life Science Center Düsseldorf
Merowingerplatz 1, Düsseldorf, 40225

Veranstaltungstyp

Single Cell Technologies and their Fields of Application (Tumor Cells)

With ‘Trends in Single Cell Analysis #9’ we will continue our event format ‘Life Science Innovation’, which provides insights into innovative research topics and current developments in Duesseldorf, NRW and beyond.

We are thrilled to welcome experts from various fields to discuss cutting-edge advancements in liquid biopsy with a focus on circulating tumor cells (CTCs). Avanish Mishra from Harvard Medical School will present their new microfluidic technologies to isolate and molecularly profile CTCs from whole Diagnostic leukapheresis products generated from several litres
of blood and will discuss the clinical implications of this advancement.

Amin El-Heliebi from the Medical University Graz will share invaluable insights into his work on liquid biopsies, focusing on their technologies to evaluate CTCs and circulating tumor DNA (ctDNA) in advanced prostate cancer. His research aims to unravel the complexities of metastatic disease by tracing liquid biopsies back to their originating tumor mass, offering unprecedented opportunities for early detection and intervention.

Lastly, Jurij Kintz from Sartorius will introduce the innovative CellCelector Flex system, designed to detect and micromanipulate single CTCs with unparalleled precision.

Programme
Welcoming speech: Dr. Thomas Heck, Life Science Center Duesseldorf

Prof. Dr. Hans Neubauer, PhD, University Hospital Duesseldorf

Academia
Moderation: Prof. Dr. Hans Neubauer, PhD, University Hospital Duesseldorf

  • Comprehensive tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of DLA products
    Avanish Mishra, Instructor, Center for Engineering in Medicine & Surgery, Krantz Family Center for Cancer Research, Harvard Medical School and MGH, Boston, USA

Moderation: Prof. Dr. Nikolas Stoeklein, MD, University Hospital Duesseldorf

  • Multi-analyte liquid biopsy monitoring of drug resistance in metastatic prostate cancer
    Amin El-Heliebi, PhD; Medical University Graz, Gottfried Schatz Research Center, Division of Cell Biology, Histology & Embryology, Graz, Austria

Companies
Moderation: Dr. André Franken, PhD, University Hospital Duesseldorf

  • Automated isolation of rare cells – detection and transfer of CTCs using the CellCelector Flex
    Jurij Kintz, M. Sc. in Biochemistry, Field Application Specialist for the CellCelector Flex

Organizer: LifeScienceNet Duesseldorf and the Liquid Biopsy Center Duesseldorf (LBCD) of the University Hospital Duesseldorf

Anmeldung

Buchungen sind für diese Veranstaltung nicht mehr möglich.